Long-term, open-label, safety study of once-daily ropinirole extended/prolonged release in early and advanced Parkinson's disease

2014 ◽  
Vol 126 (1) ◽  
pp. 30-38 ◽  
Author(s):  
Clare W. Makumi ◽  
Afsaneh Asgharian ◽  
Jeffrey Ellis ◽  
Soraya Shaikh ◽  
Teri Jimenez ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Prolonged Release ◽  
Open Label ◽  
Safety Study ◽  
Once Daily ◽  
Advanced Parkinson’S Disease

Long-term, Open-label Study of Once-daily Ropinirole Prolonged Release in Early Parkinson's Disease

2011 ◽  
Vol 121 (5) ◽  
pp. 246-253 ◽  
Author(s):  
Robert A. Hauser ◽  
Heinz Reichmann ◽  
Mark Lew ◽  
Afsaneh Asgharian ◽  
Clare Makumi ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Prolonged Release ◽  
Open Label ◽  
Once Daily ◽  
Open Label Study ◽  
Label Study ◽  
Early Parkinson’S Disease

Risperidone in levodopa-induced psychosis in advanced parkinson's disease: An open-label, long-term study

1997 ◽  
Vol 12 (4) ◽  
pp. 610-612 ◽  
Author(s):  
Giuseppe Meco ◽  
Andrea Alessandri ◽  
Patrizia Giustini ◽  
Vincenzo Bonifati
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Open Label ◽  
Term Study ◽  
Advanced Parkinson’S Disease ◽  
Long Term Study
Sign in / Sign up

Export Citation Format

Share Document